Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Ovarian Neoplasms 39Carcinoma, Ovarian Epithelial 20Testicular Neoplasms 16Sarcoma 15Testicular Germ Cell Tumor 12Neuroectodermal Tumors, Primitive, Peripheral 9Fallopian Tube Neoplasms 9Central Nervous System Neoplasms 8Teratoma 7Neuroblastoma 7Kidney Neoplasms 7Wilms Tumor 6Endometrial Neoplasms 6Uterine Cervical Neoplasms 5Ovarian Germ Cell Cancer 5Osteosarcoma 5Endodermal Sinus Tumor 5Seminoma 4Retinoblastoma 4Medulloblastoma 4Head and Neck Neoplasms 4Fibrosarcoma 4Chondrosarcoma 4Carcinoma, Embryonal 4Breast Neoplasms 4Astrocytoma 4Optic Nerve Glioma 3Neoplasms 3Melanoma 3Malignant mesenchymal tumor 3

Interventions

Thiotepa 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Busulfan 1Bone Marrow Transplantation 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors × Filgrastim × Gynecologic × Clear all
NCT00003926 2017-11-29

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
13 enrolled
CNSGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcoma

Ovarian Germ Cell Cancer, Astrocytoma, Brain Neoplasms, Chordoma, Ependymoma, Glioma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Hepatoblastoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡